With the high costs of care in oncology, value-based care is extremely important, but the transition is challenging when providers are still being paid by fee for service, too, explained Lalan Wilfong, MD, senior vice president, value-based care, Thyme Care.
This transcript has been lightly edited.
Transcript
What was discussed about value-based care in your COA session?
Value-based care is super important for oncology delivery at this time, because of the costs of care that we’re facing, and specifically in the 2 sessions I’m moderating, one with the payers [they] have a deep understanding, from a payer perspective, of what motivates them to pursue value-based care models in oncology, and what steps do they need to take to make sure models are successful for them as a payer. And then the other session, we’re going to talk about utilization management, the pros and cons of utilization management and how that needs to adapt and change to ensure all [stakeholders] are getting what they need from the delivery of care that we provide.
Read more: https://www.ajmc.com/view/the-challenge-of-living-in-both-ffs-and-value-based-care-worlds
